Clinical Trials Directory

Trials / Completed

CompletedNCT01243138

Africa and Middle East Cardiovascular Epidemiological Study

Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East Region

Status
Completed
Phase
Study type
Observational
Enrollment
4,386 (actual)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a cross-sectional, epidemiological study to determine the prevalence of cardiovascular risk factors such as obesity, smoking, dyslipidemia, diabetes mellitus and hypertension in patients attending General Practice clinics in the Africa and Middle East region. A total of 4300 patients will be evaluated. In patients who are found to have previously been diagnosed with cardiovascular (CV) risk factors such as dyslipidemia or hypertension, the level of control of their respective conditions will also be evaluated.

Detailed description

This is a cross-sectional, epidemiological study. In the course of this study, 4,300 persons from general practice, and other non specialist clinics of selected countries of the Africa and Middle East region, will be evaluated for the presence of cardiovascular (CV) risk factors such as obesity, smoking, dyslipidaemia, diabetes mellitus and hypertension. The degree of control of hypertension and dyslipidaemia in those previously diagnosed with these conditions will also be assessed. All medications used for CV risk factor control will also be ascertained. Patient evaluation will be done by physicians in charge of the selected clinics (who will be trained for case report forms completion) over one visit, through history taking, clinical examination as well as laboratory investigations. Every fifth patient seen on a particular day, fulfilling the inclusion and exclusion criteria would be included in the study.

Conditions

Timeline

Start date
2011-07-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2010-11-18
Last updated
2021-02-18

Locations

73 sites across 14 countries: Algeria, Cameroon, Egypt, Ghana, Jordan, Kenya, Kuwait, Lebanon, Nigeria, Saudi Arabia, Senegal, South Africa, Tunisia, United Arab Emirates

Source: ClinicalTrials.gov record NCT01243138. Inclusion in this directory is not an endorsement.